Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000946644-13-000017
Filing Date
2013-08-09
Accepted
2013-08-09 16:10:30
Documents
12
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q heb-2013630x10q.htm 10-Q 882528
2 EXHIBIT 10.1 heb-2013630xex101.htm EX-10.1 13659
3 EXHIBIT 31.1 heb-2013630xex311.htm EX-31.1 13123
4 EXHIBIT 31.2 heb-2013630xex312.htm EX-31.2 13186
5 EXHIBIT 32.1 heb-2013630xex321.htm EX-32.1 6487
6 EXHIBIT 32.2 heb-2013630xex322.htm EX-32.2 6573
  Complete submission text file 0000946644-13-000017.txt   9645206

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT heb-20130630.xml EX-101.INS 1112535
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT heb-20130630.xsd EX-101.SCH 41320
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT heb-20130630_cal.xml EX-101.CAL 66452
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT heb-20130630_def.xml EX-101.DEF 170961
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT heb-20130630_lab.xml EX-101.LAB 479882
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT heb-20130630_pre.xml EX-101.PRE 288922
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27072 | Film No.: 131026699
SIC: 2836 Biological Products, (No Diagnostic Substances)